Inactivation of viruses in labile blood derivatives. II. Physical methods. 1985

B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker

The thermal inactivation of viruses in labile blood derivatives was evaluated by addition of marker viruses (VSV, Sindbis, Sendai, EMC) to anti-hemophilic factor (AHF) concentrates. The rate of virus inactivation at 60 degrees C was decreased by at least 100- to 700-fold by inclusion of 2.75 M glycine and 50 percent sucrose, or 3.0 M potassium citrate, additives which contribute to retention of protein biologic activity. Nonetheless, at least 10(4) infectious units of each virus was inactivated within 10 hours. Increasing the temperature from 60 to 70 or 80 degrees C caused a 90 percent or greater loss in AHF activity. An even greater decline in the rate of virus inactivation was observed on heating AHF in the lyophilized state, although no loss in AHF activity was observed after 72 hours of heating at 60 degrees C. Several of the proteins present in lyophilized AHF concentrates displayed an altered electrophoretic mobility as a result of exposure to 60 degrees C for 24 hours. Exposure to lyophilized AHF to irradiation from a cobalt 60 source resulted in an acceptable yield of AHF at 1.0, but not at 2.0, megarads. At 1 megarad, greater than or equal to 6.0 logs of VSV and 3.3 logs of Sindbis virus were inactivated.

UI MeSH Term Description Entries
D002951 Citrates Derivatives of CITRIC ACID.
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005612 Freeze Drying Method of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products. Lyophilization,Drying, Freeze,Dryings, Freeze,Freeze Dryings,Lyophilizations
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D014775 Virus Activation The mechanism by which latent viruses, such as genetically transmitted tumor viruses (PROVIRUSES) or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses. Prophage Excision,Prophage Induction,Virus Induction,Viral Activation,Activation, Viral,Activation, Virus,Activations, Viral,Activations, Virus,Excision, Prophage,Excisions, Prophage,Induction, Prophage,Induction, Virus,Inductions, Prophage,Inductions, Virus,Prophage Excisions,Prophage Inductions,Viral Activations,Virus Activations,Virus Inductions

Related Publications

B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker
January 1988, Vox sanguinis,
B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker
January 1960, Annals of the New York Academy of Sciences,
B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker
February 1991, Transfusion,
B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker
June 2001, Transfusion medicine (Oxford, England),
B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker
June 2001, Transfusion medicine (Oxford, England),
B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker
October 1992, Photochemistry and photobiology,
B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker
January 1994, Journal of photochemistry and photobiology. B, Biology,
B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker
January 1983, Reviews of infectious diseases,
B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker
June 2001, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
B Horowitz, and M E Wiebe, and A Lippin, and J Vandersande, and M H Stryker
September 1967, Journal of medicinal chemistry,
Copied contents to your clipboard!